CYSTADROPS 3.8 mg/ml, eye drop solution bottle, 5 ml
Active ingredients: Cysteamine hydrochloride, Cysteamine
Commercialized according to BDPMDispensing in France: Prescription only
Eye drop solutionbottle, 5 mlophtalmique
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- CYSTADROPS 3,8 mg/mL, collyre en solution
- Pharmaceutical form
- collyre en solution
- Route of administration
- ophtalmique
- Presentation description
- 1 flacon(s) en verre jaune(brun) de 5 ml avec compte-gouttes
- Marketing authorisation holder
- RECORDATI RARE DISEASES
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 25 Sept 2017
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65839815CIP73008152CIP133400930081525Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE DE MERCAPTAMINEcollyre | — | SA |
| MERCAPTAMINEcollyre | 3,8 mg · 1 mL | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.